Диссертация (1141102), страница 19

Просмтор этого файла доступен только зарегистрированным пользователям. Но у нас супер быстрая регистрация: достаточно только электронной почты!

Текст из файла (страница 19)

Boldur // DiabetMed. – 2004. – Vol. 21. – p. 705-709/110208.Smith, D.E. A central nervous system-restricted isoform of the interleukin-1 receptor accessory protein modulates neuronal responses to interleukin-1 / D.E.Smith, B.P. Lipsky, C. Russell, et al. // Immunity.

– 2009. - №30(6). –Р.817-831.209.So, A. A pilot study of IL-1 inhibition by anakinra in acute gout. / A. So,T. De Smedt, S. Revaz // Arthritis Res Ther. – 2007. - №9(2). – Р.28.210.So, A. Canakinumab for the treatment of acute flares in difficult-to-treatgouty arthritis: Results of a multicenter, phase II, dose-ranging study / A. So, M.De Meulemeester, A. Pikhlak, et al. // Arthritis Rheum. – 2010. -№62(10). –Р.3064-3076.211.Stienstra, R.

The inflammasome-mediated caspase-1 activation controlsadipocyte differentiation and insulin sensitivity / R. Stienstra, L.A. Joosten, T.Koenen, et al. // Cell Metab. – 2010. - №12(6). – Р.593-605.212.Terkeltaub, R. Update on gout: new therapeutic strategies and options / R.Terkeltaub // Nat Rev Rheumatol. – 2010. - №6(1) . – Р.30-38.213.Tiemann, A.H. Principles of the therapy of bone infections in adultextremities: Are there any new developments? / A.H. Tiemann, G.O.

Hofmann //Strategies Trauma Limb Reconstr. – 2009. – V. 4, №2. – Р. 57-64.214.Vambutas, A. Alternate splicing of interleukin-1 receptor type II (IL1R2)in vitro correlates with clinical glucocorticoid responsiveness in patients withAIED / A. Vambutas, J. DeVoti, E. Goldofsky // PLoS One. – 2009. -№4. –Р.5293.215.Van Asseldonk, E.J.

The effect of the interleukin-1 cytokine familymembers IL-1F6 and IL-1F8 on adipocyte differentiation / E.J. Van Asseldonk,R. Stienstra, T.B. Koenen, et al. // Obesity. – 2010. -№18(11). – Р.2234-2236.216.Van de Veerdonk, F.L. Mycobacterium tuberculosis induces IL-17Aresponses through TLR4 and dectin-1 and is critically dependent on endogenousIL-1 / F.L. Van de Veerdonk, A.C. Teirlinck, J.

Kleinnijenhuis, et al. // J LeukocBiol. – 2010. - №88(2). – Р.227-232.217.Van de Veerdonk, F.L. Reactive oxygen species-independent activation ofthe IL-1beta inflammasome in cells from patients with chronic granulomatous111disease / F.L. van de Veerdonk, S.P. Smeekens, L.A. Joosten, et al // Proc NatlAcad Sci U S A. – 2010. - №107(7). – Р.3030-3033.218.Wagner, F.W. A classification and treatment program for diabetic,neuropatic and dysvascular foot problems / F.W.

Wagner // In The AmericanAcademy of Ortopaedic Surgeons instructional course lectures. – St. Louis. –Mosby Year Book. – 1979. – P. 143–165.219.Wald, D. SIGIRR, a negative regulator of Toll-like receptor-interleukin 1receptor signaling / D. Wald, J. Qin, Z. Zhao, et al. // Nat Immunol.-2003. №4(9). – Р.920-927.220.Weber, A. Interleukin-1 (IL-1) pathway / A. Weber, P. Wasiliew, M.Kracht // Sci Signal. – 2010. - №3. – Р. 13.221.Zhou, R. Thioredoxin-interacting protein links oxidative stress toinflammasome activation / R. Zhou, A.

Tardivel, B. Thorens // J. Nat Immunol. –2010. - №11(2). – Р.136-140..

Характеристики

Список файлов диссертации